Seeking Alpha

  InVivo Therapeutics Holdings Corp (NVIV) - OTCQB

  • Herbert Samuel Jennings | Send Message 26 Dec 2013

    Major news for $NVIV. The FDA just granted conditional approval for human testing the scaffold. It would appear NVIV is back on track!
      NVIV vs. ETF Alternatives
      Company Description
      InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and... More
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States